217 related articles for article (PubMed ID: 14603994)
1. Effect of sex hormones on experimental autoimmune uveoretinitis (EAU).
Buggage RR; Matteson DM; Shen DF; Sun B; Tuaillon N; Chan CC
Immunol Invest; 2003 Nov; 32(4):259-73. PubMed ID: 14603994
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
[TBL] [Abstract][Full Text] [Related]
3. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT
Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518
[TBL] [Abstract][Full Text] [Related]
4. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis.
Takeuchi M; Yokoi H; Tsukahara R; Sakai J; Usui M
Jpn J Ophthalmol; 2001; 45(5):463-9. PubMed ID: 11583666
[TBL] [Abstract][Full Text] [Related]
7. Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody.
Zhang R; Qian J; Guo J; Yuan YF; Xue K
Curr Eye Res; 2009 Apr; 34(4):297-303. PubMed ID: 19373578
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene.
De Kozak Y; Thillaye-Goldenberg B; Naud MC; Da Costa AV; Auriault C; Verwaerde C
Clin Exp Immunol; 2002 Nov; 130(2):212-23. PubMed ID: 12390308
[TBL] [Abstract][Full Text] [Related]
9. Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats.
Okada AA; Sakai J; Usui M; Mizuguchi J
Ocul Immunol Inflamm; 1998 Jun; 6(2):111-20. PubMed ID: 9689641
[TBL] [Abstract][Full Text] [Related]
10. Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase type 2.
Thillaye-Goldenberg B; Goureau O; Naud MC; de Kozak Y
J Neuroimmunol; 2000 Oct; 110(1-2):31-44. PubMed ID: 11024532
[TBL] [Abstract][Full Text] [Related]
11. Effect of type I interferon on experimental autoimmune uveoretinitis in rats.
Okada AA; Keino H; Fukai T; Sakai J; Usui M; Mizuguchi J
Ocul Immunol Inflamm; 1998 Dec; 6(4):215-26. PubMed ID: 9924918
[TBL] [Abstract][Full Text] [Related]
12. Identification of Th2-type suppressor T cells among in vivo expanded ocular T cells in mice with experimental autoimmune uveoretinitis.
Keino H; Takeuchi M; Suzuki J; Kojo S; Sakai J; Nishioka K; Sumida T; Usui M
Clin Exp Immunol; 2001 Apr; 124(1):1-8. PubMed ID: 11359436
[TBL] [Abstract][Full Text] [Related]
13. Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody.
Ishida W; Fukuda K; Sakamoto S; Koyama N; Koyanagi A; Yagita H; Fukushima A
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8224-30. PubMed ID: 21896864
[TBL] [Abstract][Full Text] [Related]
14. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
[TBL] [Abstract][Full Text] [Related]
16. [The onset mechanism of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein].
Usui M
Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1580-607. PubMed ID: 1283051
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
Miyazaki A; Kitaichi N; Ohgami K; Iwata D; Jin XH; Iwabuchi K; Morohashi T; Ohno S; OnoƩ K
Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):747-57. PubMed ID: 18087711
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.
Fang CB; Zhou DX; Zhan SX; He Y; Lin Z; Huang C; Li J
PLoS One; 2013; 8(4):e62071. PubMed ID: 23626769
[TBL] [Abstract][Full Text] [Related]
19. Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): differences between EAU induced by IRBP and by S-antigen.
Fox GM; Kuwabara T; Wiggert B; Redmond TM; Hess HH; Chader GJ; Gery I
Clin Immunol Immunopathol; 1987 May; 43(2):256-64. PubMed ID: 3494559
[TBL] [Abstract][Full Text] [Related]
20. Role of T-cell receptor V beta 8.3 peptide vaccine in the prevention of experimental autoimmune uveoretinitis.
Zhang R; Yang PZ; Wu CY; Jin HL; Li B; Huang XK; Zhou HY; Gao Y; Zhu LX; Kijlstra A
Chin Med J (Engl); 2006 May; 119(9):740-8. PubMed ID: 16701014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]